Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) Peptid
CHRNA3
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN937844
-15% Promotion 2026
324,80 €
Sparen Sie 57,32 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 26 Werktagen
Kurzübersicht für Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) Peptid (ABIN937844)
Target
CHRNA3
(Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- EHRLFERLFE DYNEIIRPVA NVSDPVIIHF EVSMSQLVKV DEVNQIMETN
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA3 antibody,
Alternative Names: CHRNA3 control peptide, CHRNA3 antibody Blocking Peptide, Anti-CHRNA3 Blocking Peptide, Cholinergic Receptor Nicotinic Alpha 3 Blocking Peptide, MGC104879 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
-
Hintergrund
- The CHRNA3 subunit is expressed in the soma of the majority of pyramidal cells, with the most alpha 3 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma.
-
Molekulargewicht
- 57 kDa
Target
-
Sie sind hier:
